User profiles for Joel J. Heidelbaugh

Joel Heidelbaugh

University of Michigan
Verified email at umich.edu
Cited by 7037

[HTML][HTML] Management of erectile dysfunction

JJ Heidelbaugh - American Family Physician, 2010 - aafp.org
Erectile dysfunction (ED) is the most common sexual problem in men. The incidence increases
with age and affects up to one third of men throughout their lives. It causes a substantial …

Overutilization of proton-pump inhibitors: what the clinician needs to know

JJ Heidelbaugh, AH Kim, R Chang… - Therapeutic …, 2012 - journals.sagepub.com
Proton-pump inhibitors (PPIs) remain the leading evidence-based therapy for upper
gastrointestinal disorders, including gastroesophageal reflux disease, dyspepsia, and peptic ulcer …

Peyronie's disease: AUA guideline

…, MM Faraday, LS Hakim, JJ Heidelbaugh… - The Journal of …, 2015 - auajournals.org
Purpose : The purpose of this guideline is to provide a clinical framework for the diagnosis
and treatment of Peyronie’s disease. Materials and Methods : A systematic review of the …

Proton pump inhibitors and risk of vitamin and mineral deficiency: evidence and clinical implications

JJ Heidelbaugh - Therapeutic advances in drug safety, 2013 - journals.sagepub.com
Proton pump inhibitors (PPIs) remain the superior choice worldwide in antisecretory therapy
in the evidence-based treatment of upper gastrointestinal disorders including …

Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk in PPI

JJ Heidelbaugh, KL Goldberg… - Official journal of the …, 2009 - journals.lww.com
Proton pump inhibitors (PPIs) are superior to histamine-2 receptor antagonists for the
treatment of gastroesophageal reflux disease (GERD) and erosive esophagitis. Antisecretory …

[HTML][HTML] Management of the ingrown toenail

JJ Heidelbaugh, H Lee - American family physician, 2009 - aafp.org
Ingrown toenail, or onychocryptosis, most commonly affects the great toenail. Many anatomic
and behavioral factors are thought to contribute to ingrown toenails, such as improper …

Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting.

JJ Heidelbaugh, KL Goldberg… - The American journal of …, 2010 - europepmc.org
Objectives To determine the prevalence and economic effect of inappropriate proton pump
inhibitor (PPI) use in an ambulatory care setting. Study design

American Gastroenterological Association Institute Guideline on the pharmacological management of irritable bowel syndrome

DS Weinberg, W Smalley, JJ Heidelbaugh… - …, 2014 - gastrojournal.org
(AGA) on the use of pharmacological agents for the treatment of irritable bowel syndrome (IBS)
in adults. The guideline was developed by the Clinical Practice and Quality Measures …

Corrigendum: An evidence-based position statement on the management of irritable bowel syndrome

…, S Nancey, B Flourie, JJ Heidelbaugh… - American Journal of …, 2009 - journals.lww.com
On page S5, in the left column under “Effectiveness of antibiotics in the management of irritable
bowel syndrome,” there is an error in the sentence that begins “Rifaximin is not Food and …

American Gastroenterological Association institute guideline on the use of thiopurines, methotrexate, and anti–TNF-α biologic drugs for the induction and maintenance …

JP Terdiman, CB Gruss, JJ Heidelbaugh… - …, 2013 - gastrojournal.org
This document presents the official recommendations of the American Gastroenterological
Association Institute (AGA) on the use of thiopurines, methotrexate, and anti–tumor necrosis …